Skip to main content
. 2018 Nov 21;2018(11):CD012125. doi: 10.1002/14651858.CD012125.pub2

Comparison 1. Corticosteroids versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Pain ‐ absence of pain 1 49 Risk Ratio (M‐H, Random, 95% CI) 1.33 [1.03, 1.72]
2 Pain ‐ number of days until pain free 1 49 Mean Difference (IV, Random, 95% CI) ‐3.58 [‐7.41, 0.25]
3 Number of participants with normal physical joint function ‐ number of days until normal function of the joint 1 49 Mean Difference (IV, Random, 95% CI) ‐2.07 [‐5.47, 1.33]
4 Number of participants with normal physical joint function ‐ number of days until full range of movement 1 49 Mean Difference (IV, Random, 95% CI) ‐5.24 [‐10.37, ‐0.11]
5 Number of participants with normal physical joint function ‐ normal function at the end of treatment (short term) 1 100 Risk Ratio (M‐H, Random, 95% CI) 1.41 [1.16, 1.72]
6 Number of participants with normal physical joint function ‐ normal function at 6 months of follow‐up (medium term) 1 100 Risk Ratio (M‐H, Random, 95% CI) 1.58 [1.27, 1.97]
7 Number of participants with normal physical joint function ‐ normal function at 12 months of follow‐up (long term) 1 100 Risk Ratio (M‐H, Random, 95% CI) 1.32 [1.12, 1.57]
8 Number of participants with normal physical joint function ‐ number of days until resolution of symptoms 1 100 Mean Difference (IV, Random, 95% CI) ‐5.47 [‐6.98, ‐3.96]
9 Number of days of antibiotic treatment ‐ number of days of intravenous antibiotic treatment 2 149 Mean Difference (IV, Random, 95% CI) ‐2.77 [‐4.16, ‐1.39]
10 Number of days of antibiotic treatment ‐ number of total days of antibiotic treatment 2 149 Mean Difference (IV, Random, 95% CI) ‐3.11 [‐6.94, 0.73]